reference/32838835

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32838835

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	689.e10
issn	0002-8703
issueIdentifier	3
pageRange	689.e1-689.e10
publicationName	American Heart Journal
startingPage	689.e1
bibliographicCitation	Greenbaum AB, Grines CL, Bittl JA, Becker RC, Kereiakes DJ, Gilchrist IC, Clegg J, Stankowski JE, Grogan DR, Harrington RA, Emanuelsson H, Weaver WD. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial. Am Heart J. 2006 Mar;151(3):689.e1–689.e10. doi: 10.1016/j.ahj.2005.11.014. PMID: 16504633.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_871a3a1d4d106822d813099f5ec84a5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa8f92d5020a4a9b2a01d283acf5ca44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acdd40fd436b859a6c17c949e2def9f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76b5b19aaedff712d6ce2c681efc56e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40eca1b199293e5d94872d07b10024e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa0bdc0a911f934cc4fbd852d38e4ed1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7e8b6111c5314f402d5e21139ac6120 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfa5f33f01b61a91b0cda838cc78fa06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_844449b4c43d381872a60c087de2a806 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9065acf6142f6799d5e9e9aa9fe31416 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae6edb95bb86886d01d1b3731693caa8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55edd3a8f25bff1be8db158953aaa891
date	200603
identifier	https://doi.org/10.1016/j.ahj.2005.11.014 https://pubmed.ncbi.nlm.nih.gov/16504633
isPartOf	https://portal.issn.org/resource/ISSN/0002-8703 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/398
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0421877 http://id.nlm.nih.gov/mesh/M0227707 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0011126 http://id.nlm.nih.gov/mesh/M0028424 http://id.nlm.nih.gov/mesh/M0000389 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007140Q000627 http://id.nlm.nih.gov/mesh/D015906 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D019039Q000037 http://id.nlm.nih.gov/mesh/D003327Q000628 http://id.nlm.nih.gov/mesh/D000249Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000077284 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000249Q000627 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D010975Q000008 http://id.nlm.nih.gov/mesh/D010974Q000187 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000249Q000008 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10260031 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9854012 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248489331 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129740296 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129352801 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 66.